Related Experiment Video
Updated: Jul 16, 2026

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats
Published on: October 24, 2016
Intrapericardial neuroendocrine tumour in a dog
This report describes an 11-year-old dog with a rare heart-base tumor that caused long-term fluid buildup in the body cavities. Surgeons removed the mass, which was identified as a neuroendocrine tumor likely originating from ectopic thyroid tissue. The case highlights how difficult these tumors are to diagnose using standard ultrasound imaging alone.
Area of Science:
- Veterinary oncology and thoracic surgery research
- Intrapericardial neuroendocrine tumour diagnostics within clinical pathology
Background:
No prior work had resolved the diagnostic challenges associated with rare heart-base masses in geriatric canine patients. That uncertainty drove clinicians to rely on standard imaging techniques that often miss ectopic tissue. Prior research has shown that tricavitary effusion frequently indicates underlying cardiac or neoplastic disease. This gap motivated a closer look at atypical presentations of pericardial masses. It was already known that neuroendocrine tumors can arise in unusual anatomical locations. However, the specific manifestation of thyroid-derived cells within the pericardium remains poorly documented in veterinary literature. That knowledge gap complicates surgical planning for practitioners encountering similar clinical signs. No prior work had fully characterized the imaging limitations for this specific presentation.
Purpose Of The Study:
The aim of this report is to document the clinical presentation and diagnostic challenges of an intrapericardial neuroendocrine tumour in a dog. This study addresses the difficulty of identifying heart-base masses that do not follow typical presentation patterns. The authors seek to highlight the limitations of standard echocardiography for detecting poorly marginated pericardial lesions. That uncertainty drove the need for a detailed review of the diagnostic pathway for this specific patient. The report examines how long-term tricavitary effusion can mask underlying neoplastic processes in geriatric animals. This gap motivated the team to share the findings from the computed tomography imaging and subsequent histopathology. The researchers intend to provide a reference for clinicians encountering similar rare presentations in veterinary practice. This work emphasizes the importance of considering ectopic thyroid tissue in the differential diagnosis for pericardial masses.
Main Methods:
The clinical team conducted a retrospective analysis of a single canine case involving a complex heart-base mass. Review approach involved documenting the patient's nine-month history of systemic symptoms and fluid accumulation. Practitioners performed transthoracic echocardiography to evaluate the cardiac structure and identify potential obstructions. The diagnostic protocol included thoracic computed tomography to assess the mass's margins and enhancement patterns. Surgeons executed a median sternotomy to gain access to the thoracic cavity for mass removal. The team employed subtotal pericardiectomy to address the pericardial involvement and facilitate the marsupialisation of the fluid-filled structure. Pathologists examined the extirpated sternal lymph nodes to characterize the cellular composition of the neoplasia. This comprehensive evaluation allowed the researchers to correlate the clinical presentation with the final histopathological findings.
Main Results:
The strongest finding indicates that the mass was a neuroendocrine tumor consistent with ectopic thyroid tissue. Histopathology revealed expansile, well-demarcated, and unencapsulated nodules within the sternal lymph nodes. Echocardiography identified a fluid-filled structure starting at the mid-right ventricle and extending to the middle of the right atrium. This structure caused almost complete compression of the right atrium and the cranial vena cava. Computed tomography showed a heterogeneously enhancing and poorly marginated mass within the cranial pericardium. The patient had suffered from a nine-month history of tricavitary effusion, dyspnoea, and lethargy prior to the intervention. Unfortunately, the dog required euthanasia due to intractable pleural effusion following the surgical procedure. The authors report that the tumor's location and unusual presentation created significant challenges for standard diagnostic imaging.
Conclusions:
The authors propose that ectopic thyroid tissue should be considered when evaluating atypical pericardial masses in dogs. This synthesis suggests that standard echocardiography may lack the sensitivity required to detect these specific neoplastic structures. The findings imply that thoracic computed tomography serves as a superior diagnostic tool for identifying poorly marginated heart-base lesions. Clinicians should prioritize advanced imaging when patients present with persistent, unexplained fluid accumulation in multiple body cavities. The report highlights that early surgical intervention remains the primary goal for managing such aggressive pericardial growths. The authors note that the unusual location of this tumor likely contributed to the diagnostic delay observed in this case. Future clinical practice might benefit from integrating earlier cross-sectional imaging to improve surgical outcomes for similar patients. The team concludes that while rare, these tumors represent a significant differential diagnosis for pericardial effusion.
Frequently Asked Questions
The researchers propose that the tumor originated from ectopic thyroid tissue, as indicated by the histopathological analysis of the sternal lymph nodes. This diagnosis was supported by the presence of expansile, unencapsulated nodules of neoplastic cells, which differed from typical primary cardiac tumors.
The primary diagnostic tool used for initial assessment was transthoracic echocardiography, which revealed a fluid-filled structure. However, this method struggled to identify the neoplasia due to the mass's location, whereas thoracic computed tomography provided a clearer view of the heterogeneously enhancing, poorly marginated lesion.
The surgical team performed a median sternotomy and subtotal pericardiectomy. This approach was necessary to access the cranial aspect of the pericardium where the mass was located, allowing for the removal of the structure via marsupialisation and the extirpation of enlarged lymph nodes.
The authors utilized histopathological examination of the sternal lymph nodes to confirm the diagnosis. This data type was critical because the primary mass was poorly marginated, making visual identification during surgery difficult without the subsequent microscopic analysis of the surrounding lymphatic tissue.
The patient exhibited a nine-month history of tricavitary effusion, dyspnoea, and lethargy. These clinical signs were caused by the mass compressing the right atrium and the cranial vena cava, which hindered normal blood flow and led to the persistent accumulation of fluid.
The researchers suggest that earlier use of thoracic computed tomography might have facilitated timely surgical intervention. They propose that the unusual presentation and location of the mass likely hindered the efficacy of standard ultrasound, potentially delaying the identification of the neoplasia.

